Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review.

This study investigates the use of hyaluronan injections for osteoarthritis treatment, particularly focusing on their impact on reducing pain and increasing joint functionality, and compares them with other treatments like local steroid injections.

Study Context

• Intraarticular injections of hyaluronan, also known as viscosupplementation, have been used as a treatment method for osteoarthritis for the past two decades. They are most commonly used for osteoarthritis in the knee.
• The normal dosage for this treatment ranges from 20 to 25 mg of hyaluronan with molecular rates from 500,000 to 2,500,000 M(r) and is administered through a series of 2 to 10 weekly injections.

Study Findings

• The treatment results in pain relief within a few days, with the effects progressing over a span of a few weeks. The relief is often long-lasting, usually remaining for several months. There’s evidence that the benefits of the injections can last from 6 months to a year.
• Patients typically tolerate the hyaluronan injections well, with the effectiveness rate being between 65% to 80%. This is noticeably higher than the 30% to 35% response rate in the control group who didn’t receive the hyaluronan injections.
• The study found the effect of hyaluronan to be significantly longer lasting compared to local steroid injections, the other popular treatment option for osteoarthritis.
• The researchers suggest that using even more viscoelastic preparations of hyaluronan could potentially produce better results, making the treatment more appealing.

Study Implications

• This study underscores the potential effectiveness of hyaluronan injections in alleviating the symptoms of osteoarthritis. As a treatment option, they seem to provide substantial pain relief, have a higher response rate than other treatments like local steroid injections, and have the potential for an even longer-term benefit.
• The positive reception of hyaluronan injections among patients speaks well to its tolerance and points to it as a viable and preferable treatment solution.
• Further research into making hyaluronan more viscoelastic might result in even more effective osteoarthritis treatments in the future.